Fentanyl self-testing outside supervised injection settings to prevent opioid overdose

Do we know enough to promote it

Datos Bibliográficos

ID14907006
AutoresCatherine R Mcgowan (0000-0001-6941-6539, London School of Hygiene & Tropical Medicine, autor de correspondencia), Magdalena Harris (0000-0001-8718-8226, London School of Hygiene & Tropical Medicine), Lucy Platt (0000-0002-0943-0045, London School of Hygiene & Tropical Medicine), Vivian Hope (0000-0001-5712-5734, Liverpool John Moores University), Tammy Rhodes (0000-0003-2400-9838, UNSW Sydney)
Año2018
Volumen58
Páginas31-36
Fecha de publicación2018-08-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2018.04.017
PMID29758542
OpenAlexW2801139126
IdiomaEN
Citas recibidas26
Referencias citadas31

Since 2013, North America has experienced a sharp increase in unintentional fatal overdoses: fentanyl, and its analogues, are believed to be primarily responsible. Currently, the most practical means for people who use drugs (PWUD) to avoid or mitigate risk of fentanyl-related overdose is to use drugs in the presence of someone who is in possession of, and experienced using, naloxone. Self-test strips which detect fentanyl, and some of its analogues, have been developed for off-label use allowing PWUD to test their drugs prior to consumption. We review the evidence on the off-label sensitivity and specificity of fentanyl test strips, and query whether the accuracy of fentanyl test strips might be mediated according to situated practices of use. We draw attention to the weak research evidence informing the use of fentanyl self-testing strips

Anesthesia · Fentanyl · Medical emergency · Opioid · Opioid overdose · Possession (linguistics · Test (biology · Forensic Toxicology and Drug Analysis · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Internal Medicine